These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 235087)

  • 21. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
    Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mutagenicity of chemically synthesized metabolites of 16,17-dihydro-15H-cyclopenta[a]phenanthrene and its carcinogenic 11-methyl homologue.
    Papaparaskeva-Petrides C; Ioannides C; Boyd GW; Young RJ; Harvey RG; Coombs MM
    Mutagenesis; 1993 Jul; 8(4):307-10. PubMed ID: 8377648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenic activation of tris(2,3-dibromopropyl)phosphate: the role of microsomal oxidative metabolism.
    Søderlund EJ; Nelson SD; Dybing E
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):112-21. PubMed ID: 40390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function characterization of phenanthridinium compounds as mutagens in Salmonella.
    Fukunaga M; Yielding LW
    Mutat Res; 1983 Aug; 121(2):89-94. PubMed ID: 6348533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of hycanthone ("etrenol"), some hycanthone analogs, myxin and 4-nitroquinoline-1-oxide as frameshift mutagens.
    Hartman PE; Berger H; Hartman Z
    J Pharmacol Exp Ther; 1973 Sep; 186(3):390-8. PubMed ID: 4580578
    [No Abstract]   [Full Text] [Related]  

  • 26. Dissociation of mutagenic and other toxic properties from schistosomicides.
    Bueding E
    J Toxicol Environ Health; 1975 Nov; 1(2):329-34. PubMed ID: 1206775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of mutagenicity of hycanthone in Habrobracon serinopae females.
    Smith RH
    Mutat Res; 1973 Oct; 21(5):279-81. PubMed ID: 4760255
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutagenicity of hycanthone in Drosophila: additional results and a comparison with some analogs.
    Kramers PG
    Mutat Res; 1981 Jun; 82(1):111-23. PubMed ID: 6790976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity of nitro- and amino-substituted carbazoles in Salmonella typhimurium. III. Methylated derivatives of 9H-carbazole.
    André V; Boissart C; Sichel F; Gauduchon P; Le Talaër JY; Lancelot JC; Mercier C; Chemtob S; Raoult E; Tallec A
    Mutat Res; 1997 Mar; 389(2-3):247-60. PubMed ID: 9093391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship studies on the mutagenicity of some azo dyes in the Salmonella/microsome assay.
    Lin GH; Solodar WE
    Mutagenesis; 1988 Jul; 3(4):311-5. PubMed ID: 3062318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combined testing protocol approach for mutagenicity testing.
    Connor TH; Meyne J; Molina L; Legator MS
    Mutat Res; 1979 Feb; 64(1):19-26. PubMed ID: 375079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticholinergic properties of the antischistosomal drug hycanthone.
    Hillman GR; Senft AW
    Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes.
    Niwa T; Yamazoe Y; Kato R
    Mutat Res; 1982 Aug; 95(2-3):159-70. PubMed ID: 6750381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenicity testing of some commonly used dyes.
    Chung KT; Fulk GE; Andrews AW
    Appl Environ Microbiol; 1981 Oct; 42(4):641-8. PubMed ID: 7039509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent mutagenic potential of 4-methylquinoline: metabolic and mechanistic considerations.
    Saeki K; Takahashi K; Kawazoe Y
    Biol Pharm Bull; 1996 Apr; 19(4):541-6. PubMed ID: 8860954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenicity tests on anthelmintics: microsomal activation of viprynium embonate to a mutagen.
    Macphee DG; Podger DM
    Mutat Res; 1977 Jul; 48(3-4):307-12. PubMed ID: 327314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity of some derivatives of dipyrido[1,2-a:3',2'-d]imidazoles in Salmonella typhimurium with metabolic activation by rat liver and small intestine subcellular fractions.
    N'Goy K; Saint-Ruf G; de Meester C
    Mutat Res; 1985; 156(1-2):53-9. PubMed ID: 3889627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity of natural naphthoquinones and benzoquinones in the Salmonella/microsome test.
    Tikkanen L; Matsushima T; Natori S; Yoshihira K
    Mutat Res; 1983 Oct; 124(1):25-34. PubMed ID: 6355836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
    Amin S; Hecht SS; LaVoie E; Hoffmann D
    J Med Chem; 1979 Nov; 22(11):1336-40. PubMed ID: 392098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotoxic activity of nitroaromatic explosives and related compounds in Salmonella typhimurium.
    Whong WZ; Edwards GS
    Mutat Res; 1984 Jun; 136(3):209-15. PubMed ID: 6377057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.